These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3930694)

  • 1. Biopharmaceutical evaluation of methylcellulose as an excipient for nitroglycerin tablets.
    Shibuya F; Kuramoto K; Koizumi H; Uehara N; Nakagawa F; Tamura Z; Murayama M; Kawakubo K; Kawahara T; Ohshiro M
    J Pharmacobiodyn; 1985 May; 8(5):352-6. PubMed ID: 3930694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete and delayed bioavailability of sublingual nitroglycerin.
    Noonan PK; Benet LZ
    Am J Cardiol; 1985 Jan; 55(1):184-7. PubMed ID: 3917598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of nitroglycerin and its metabolites after administration of sustained-release tablets.
    Kwon HR; Green P; Curry SH
    Biopharm Drug Dispos; 1992 Mar; 13(2):141-52. PubMed ID: 1550909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilized compressed nitroglycerin tablets.
    Goodhart FW; Gucluyildiz H; Daly RE; Chafetz L; Ninger FC
    J Pharm Sci; 1976 Oct; 65(10):1466-71. PubMed ID: 824435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a stable sublingual nitroglycerin tablet II: formulation and evaluation of tablets containing povidone.
    Fung HL; Yap SK; Rhodes CT
    J Pharm Sci; 1976 Apr; 65(4):558-60. PubMed ID: 818363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet.
    Jensen KM; Mikkelsen S
    Arzneimittelforschung; 1997 Jun; 47(6):716-8. PubMed ID: 9239449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual nitroglycerin. II. In vitro and in vivo availability of Nitrostat and Nitrobaat tablets.
    Lagas M; Duchateau AM
    Pharm Weekbl Sci; 1988 Dec; 10(6):254-8. PubMed ID: 3145488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative haemodynamic examination of Nitromint (sublingual tablet and aerosol).
    Lakos G
    Ther Hung; 1992; 40(1):12-5. PubMed ID: 1585277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioavailability of two spray formulations of nitroglycerin.
    Sanders SW; Michaelis K; Maurette JM; Jaeger H
    J Pharm Sci; 1986 Mar; 75(3):244-6. PubMed ID: 3084758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
    Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
    Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sublingual nitroglycerin in patients receiving transdermal nitroglycerin for coronary artery disease: prevention of cross-tolerance.
    Naito H; Matsuda Y; Yorozu T; Shiomi K; Maeda T; Seki K; Tada T; Fujii H
    Clin Cardiol; 1991 Aug; 14(8):644-50. PubMed ID: 1914267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of venodilatory effects of nitroglycerin spray and tablets in healthy volunteers.
    Fanelli C; Zelis R; Gascho JA
    Am J Cardiol; 1989 Mar; 63(9):637-9. PubMed ID: 2493189
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC.
    Ishikawa T; Watanabe Y; Takayama K; Endo H; Matsumoto M
    Int J Pharm; 2000 Jul; 202(1-2):173-8. PubMed ID: 10915941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sublingual tablets with nitroglycerin complexed with beta-cyclodextrin or titrated with crosspovidone--technological approach.
    Centkowska K; Sznitowska M
    Acta Pol Pharm; 2008; 65(5):585-9. PubMed ID: 19051606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative bioavailability of a new transdermal nitroglycerin delivery system.
    Noonan PK; Gonzalez MA; Ruggirello D; Tomlinson J; Babcock-Atkinson E; Ray M; Golub A; Cohen A
    J Pharm Sci; 1986 Jul; 75(7):688-91. PubMed ID: 3093667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
    Rao VM; Haslam JL; Stella VJ
    J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacodynamics of nitroglycerin for sublingual medication in ischemic heart disease].
    Savvateev KL; Metelitsa VI
    Kardiologiia; 1982 Jan; 22(1):65-70. PubMed ID: 6801369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soy polysaccharide as a novel superdisintegrant in sildenafil citrate sublingual tablets: preparation, characterization, and in vivo evaluation.
    Hosny KM; Mosli HA; Hassan AH
    Drug Des Devel Ther; 2015; 9():465-72. PubMed ID: 25624751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual nitroglycerin. I. Comparative evaluation of the physical stability of commercially available tablets.
    Lagas M; Duchateau AM
    Pharm Weekbl Sci; 1988 Dec; 10(6):246-53. PubMed ID: 3145487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.